Patents by Inventor Cris Davenport

Cris Davenport has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • pH sensitive prodrugs of 2,6-diisopropylphenol
    Patent number: 7691904
    Abstract: The present invention is directed to water-soluble derivatives of 2,6-diisopropylphenol (Propofol). The compounds act as prodrugs of 2,6-diisopropylphenol and metabolize rapidly to Propofol thereby providing an alternative to the water-insoluble 2,6-diisopropylphenol. Pharmaceutical compositions comprising these compounds, methods of induction and maintenance of anesthesia or sedation as well as methods of treating neurodegenerative diseases utilizing pharmaceutical compositions comprising these compounds and methods of preparing them are also disclosed.
    Type: Grant
    Filed: July 24, 2007
    Date of Patent: April 6, 2010
    Assignee: Auspex Pharmaceuticals, Inc
    Inventors: Subramanian Marappan, Cris Davenport, Sepehr Sarshar
  • pH sensitive prodrugs of 2,6-diisopropylphenol
    Publication number: 20080248093
    Abstract: The present invention is directed to water-soluble derivatives of 2,6-diisopropylphenol (Propofol). The compounds act as prodrugs of 2,6-diisopropylphenol and metabolize rapidly to Propofol thereby providing an alternative to the water-insoluble 2,6-diisopropylphenol. Pharmaceutical compositions comprising these compounds, methods of induction and maintenance of anesthesia or sedation as well as methods of treating neurodegenerative diseases utilizing pharmaceutical compositions comprising these compounds and methods of preparing them are also disclosed.
    Type: Application
    Filed: July 24, 2007
    Publication date: October 9, 2008
    Inventors: Subramanian Marappan, Cris Davenport, Sepehr Sarshar
  • PH sensitive prodrugs of 2,6-Diisopropylphenol
    Patent number: 7250412
    Abstract: The present invention is directed to water-soluble derivatives of 2,6-diisopropylphenol (Propofol). The compounds act as prodrugs of 2,6-diisopropylphenol and metabolize rapidly to Propofol thereby providing an alternative to the water-insoluble 2,6-diisopropylphenol. Pharmaceutical compositions comprising these compounds, methods of induction and maintenance of anesthesia or sedation as well as methods of treating neurodegenerative diseases utilizing pharmaceutical compositions comprising these compounds and methods of preparing them are also disclosed.
    Type: Grant
    Filed: March 15, 2004
    Date of Patent: July 31, 2007
    Assignee: Auspex Pharmaceuticals, Inc.
    Inventors: Subramanian Marappan, Cris Davenport, Sepehr Sarshar
  • Ph sensitive prodrugs of 2,6-diisopropylphenol
    Publication number: 20050234050
    Abstract: The present invention is directed to water-soluble derivatives of 2,6-diisopropylphenol (Propofol). The compounds act as prodrugs of 2,6-diisopropylphenol and metabolize rapidly to Propofol thereby providing an alternative to the water-insoluble 2,6-diisopropylphenol. Pharmaceutical compositions comprising these compounds, methods of induction and maintenance of anesthesia or sedation as well as methods of treating neurodegenerative diseases utilizing pharmaceutical compositions comprising these compounds and methods of preparing them are also disclosed.
    Type: Application
    Filed: March 15, 2004
    Publication date: October 20, 2005
    Inventors: Subramanian Marappan, Cris Davenport, Sepehr Sarshar